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Abstract
Rationale Neuropeptide S (NPS) displays unique pharmaco-
logical properties and induces both anxiolytic and pro-stress/
arousal activities. Previous studies performed using Wistar
rats demonstrated that NPS facilitated alcohol and cocaine
seeking but did not affect alcohol or cocaine consumption.
Objectives Here, we investigated the effects of NPS in
Marchigian Sardinian alcohol-preferring (msP) rats, a rat
strain characterized by excessive alcohol consumption comor-
bid with heightened anxiety and depressive-like phenotypes.
Specifically, we evaluated the effect of NPS on operant alco-
hol self-administration by msP rats compared to Wistar rats.
The effect of NPS on cue-induced reinstatement of alcohol
seeking inmsP rats was also evaluated. Finally, using the open
field test (OFT) and the elevated plus maze (EPM), we eval-
uated the effects of NPS on locomotor activity and anxiety.
Results NPS reduced alcohol self-administration but did not
affect cue-induced reinstatement in the msP rat. In addition,
NPS induced reinstatement of extinguished alcohol seeking in
Wistar rats without affecting alcohol intake. In the EPM task,
NPS, in accordance with its anxiolytic activity, increased the
time spent in the open arm of the arena by msP rats, although
this effect was not observed in Wistar rats.
Conclusions These data suggest that the effect of NPS is
strongly influenced by the genetic background of the animal.
In Wistar rats, NPS acts as a pro-arousal agent to promote the
reinstatement of alcohol seeking. However, when alcohol
drinking is motivated by or associated with a state of
pathological anxiety, NPS attenuates alcohol consumption
and seeking due to its anxiolytic activity.
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Introduction
Neuropeptide S (NPS) is a 20-amino-acid neuropeptide, and its
transcript is largely expressed in three brainstem areas: the lat-
eral parabrachial nucleus, the principal sensory trigeminal nu-
cleus, and the area surrounding the locus coeruleus (Liu et al.
2011; Xu et al. 2007; Xu et al. 2004). Conversely, its cognate
Gq/s G protein-coupled receptor (NPSR) is widely expressed
throughout the central nervous system (Leonard and Ring
2011; Xu et al. 2007; Xu et al. 2004). In agreement with the
wide brain distribution of NPSR, the NPS system is involved in
the modulation of a variety of functions, such as locomotion,
anxiety, stress, fear conditioning, memory, and food intake
(Pape et al. 2010; Reinscheid 2008). In addition, several pre-
clinical studies strongly indicate that the NPS system is in-
volved in drug addiction and alcohol dependence (Cannella et
al. 2012; Ghazal et al. 2013; Kallupi et al. 2010; Paneda et al.
2009; Ubaldi et al. 2016). This role of NPS was recently con-
firmed by a human study that associated increased intrinsic
activity of NPSR with more severe alcohol use disorder and
increased alcohol consumption (Laas et al. 2015).
We previously demonstrated that the injection of NPS into
Wistar rats via the intracerebroventricular (ICV) or intralateral
hypothalamus (LH) route potentiates cue-induced reinstate-
ment of alcohol seeking without altering alcohol self-
administration (Cannella et al. 2009). Subsequently, we re-
ported a similar pattern of NPS effects on cocaine seeking
(Kallupi et al. 2010; Kallupi et al. 2013). Our findings agreed
* Massimo Ubaldi
massimo.ubaldi@unicam.it
1 School of Pharmacy, Pharmacology Unit, University of Camerino,
Building of Experimental Medicine, Via Madonna delle Carceri 9,
Camerino, MC 62032, Italy
Psychopharmacology
DOI 10.1007/s00213-016-4333-7
with those of another study (Badia-Elder et al. 2008) reporting
that ICV NPS administration does not affect alcohol con-
sumption by non-preferring (NP) rats. However, these authors
also reported that NPS, at least under conditions of home cage
drinking, can decrease alcohol intake by alcohol-preferring
(P) rats. In addition, NPS exerted an anxiolytic-like effect on
a P strain but not on an NP strain (Badia-Elder et al. 2008). P
rats are characterized by an innate anxious phenotype, and it
has been hypothesized that their excessive alcohol drinking is
driven in part by the ability of alcohol to relieve them from this
negative affective state (Stewart et al. 1993).
The anxiolytic-like properties of NPS have been document-
ed in a number of studies performed under various experimen-
tal conditions (Jungling et al. 2008; Leonard et al. 2008; Lukas
and Neumann 2012; Rizzi et al. 2008; Vitale et al. 2008; Xu et
al. 2004). Hence, in P rats, NPS likely decreases alcohol con-
sumption not because it acts by modulating the rewarding
properties of ethanol but rather because of its anxiolytic-like
properties. On the other hand, in addition to its anxiolytic
activity, NPS has pro-stress and pro-arousal properties
(Okamura and Reinscheid 2007). This aspect of NPS pharma-
cology is likely related to its ability to facilitate relapse behav-
ior. Indeed, we demonstrated that NPS exacerbates the rein-
statement of alcohol and cocaine seeking via the stimulation
of hypothalamic hypocretin-1/orexin-A signaling (Cannella et
al. 2009; Kallupi et al. 2010; Ubaldi et al. 2016). Moreover,
Paneda and coworkers reported that NPS is unable to
induce reinstatement of extinguished cocaine seeking in
mice lacking the receptor corticotropin-releasing factor 1
(CRF1); this finding provides additional support for a
role of pro-arousal mechanisms in sustaining this effect
of NPS (Paneda et al. 2009).
Taken together, this evidence suggests that NPS might
have a dual and, to some extent, paradoxical effect on
alcohol drinking and seeking depending on the genetic
background and the emotional state of the animal. In the
present study, we further evaluated this hypothesis by ex-
amining the effects of NPS in Wistar rats compared to
Marchigian Sardinian alcohol-preferring (msP) rats. MsP
rats, similar to the P strain, exhibit a genetic predisposition
toward high levels of alcohol consumption; msP rats are
highly vulnerable to the reinstatement of alcohol seeking,
are hypersensitive in response to stress, and show an
anxious- and depression-like phenotype (Ciccocioppo et
al. 2006; Ciccocioppo et al. 1999; Gozzi et al. 2013;
Hansson et al. 2007; Hansson et al. 2006). In previous
studies, we proposed that msP rats consume alcohol for
self-medication purposes to alleviate their innate negative
affective state (Ciccocioppo et al. 2006; Hansson et al.
2006). Hence, considering that NPS exerts anxiolytic-like
effects, we hypothesized that NPS would reduce alcohol
consumption and seeking in these animals while exerting
no effect on the opposite effect in Wistar rats.
Materials and methods
Animals
Male Wistar rats (Charles River, Calco, Italy) and msP rats
bred at the School of Pharmacy, University of Camerino,
weighing 175–225 g at the beginning of the study were used.
Pairs of rats were housed in a roomwith an artificial 12 h/12 h
light/dark cycle (lights off at 8:00 a.m.) at constant tempera-
ture (20–22 °C) and humidity (45–55 %). All training and
experimental sessions were conducted once a day during the
nocturnal phase of the light/dark cycle. All procedures ad-
hered to the European Community Council Directive and
the National Institutes of Health Guidelines for the Care and
Use of Laboratory Animals and were approved by the Ethics
Committee of the University of Camerino (Protocol no. 1/
2012).
Intracranial surgery
Animals were anesthetized via intramuscular injection of
100–150 μl of a solution containing tiletamine hydrochloride
(58.17 mg/ml) and zolazepam hydrochloride (7.5 mg/ml). For
drug injections, guide cannulae (0.65-mm outside diameter)
were stereotaxically implanted and cemented to the skull. For
ICV cannula placement, the coordinates in millimeters with
reference to bregma were as follows: anteroposterior (AP)
−1.0, lateral (L) −1.8, and ventral (V) 2.0. All coordinates
were based on the Paxinos and Watson atlases (Paxinos and
Watson 1988) and were adjusted for the body weight of the
animals. To alleviate postoperative pain, the rats were treated
with 2.5 mg/kg of ketoprofen administered subcutaneously for
2 days. Surgery was followed by a 7-day recovery period,
during which the rats were left undisturbed in their home cage.
Before the beginning of the experiments, the animals re-
ceived ICV injections of saline to habituate them to the drug
administration procedure. Appropriate cannula placement was
verified before the experiment by performing ICV injection of
100 ng of angiotensin II; only animals showing a clear
dipsogenic response (consumption of at least 6 ml of water
within 5 min) were used for further experimentation.
Drug injection
NPS, a generous gift of Dr. R. Guerrini, University of Ferrara,
Italy, was dissolved in sterile isotonic saline and administered
intracerebroventricularly in a volume of 1 μl/rat using a
stainless-steel injector 2.5 mm longer than the guide cannula.
The injector was connected to a 10-μl Hamilton syringe. Once
the injector was introduced into the guide cannula, the NPS (or
vehicle) solution was infused by gently pushing the syringe
piston. After the infusion, the injector was left in place for
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1 min before removal to avoid liquid backflow. The NPS or
vehicle solution was injected 5min before the behavioral tests.
Operant training of alcohol self-administration
Operant training and testing were performed in self-
administration chambers (Med Associates) equipped with a
drinking reservoir (volume capacity 0.30 ml) and two retract-
able levers. Auditory and visual stimuli were presented via a
speaker and a light located on the front panel, respectively,
during the discrimination phase and the reinstatement tests.
The rats were trained to self-administer 10 % alcohol (v/v)
using a saccharin-fading procedure adapted from Weiss et al.
(1990) in 30-min daily sessions on a fixed-ratio of 1 schedule of
reinforcement. For the first 5 days of training, presses of the
active lever were reinforced by delivery of 0.2 % (w/v) saccha-
rin solution into the drinking receptacle. After the acquisition of
the saccharin-reinforced response, alcohol was added to the
saccharin solution and the alcohol and saccharin concentrations
varied every five training days according the following sched-
ule: saccharin 0.2 % (w/v) + alcohol 5 % (v/v), alcohol 5 % (v/
v), saccharin 0.2 % (w/v) + alcohol 8% (v/v), alcohol 8% (v/v),
and saccharin 0.2 % (w/v) + alcohol 10 % (v/v). The delivery of
the solutions was followed by a 5-s time-out period during
which the reinforced lever remained inactive.
Each response resulted in the delivery of 0.1 ml of fluid.
The number of operant lever presses of both the active and
inactive levers and the number of reinforcements received was
recorded for each session.
Experiment 1: effect of ICV NPS treatment on alcohol
self-administration by msP and Wistar rats
The rats (n=8/line) were trained to self-administer 10 % (v/v)
alcohol using the fading procedure described above. Once
saccharin was faded out, each alcohol delivery was paired
with the illumination of the chamber’s house light, which
signaled a 5-s time-out (TO) period. Following the acquisition
of a stable baseline of alcohol self-administration, NPS treat-
ment began. In a counterbalanced order, 5 min before the
beginning of the self-administration session, the rats received
an ICV injection of NPS (0.1, 0.5, 1.0, or 2.0 nmol/rat) or its
vehicle. Drug treatment was performed every fourth day. On
the first day after each drug injection, the rats remained in their
home cages, whereas on the 2nd and 3rd day after each drug
injection, baseline alcohol self-administration was
reestablished.
Experiment 2: effect of ICV NPS treatment on open field
test performance by msP and Wistar rats
For the open field test (OFT), the rats were placed in a
Plexiglas arena (43×43 cm) that recorded subject location
using 16 evenly spaced infrared (I/R) transmitters and re-
ceivers positioned around the periphery of the chamber
(Med Associates). The OFT was performed in a sound-
attenuated room illuminated by a dim red light (~30 lx).
The rats received an ICV injection of NPS (0.25 and
1.0 nmol/rat) 5 min before the beginning of the test.
Wistar (n=24; 8/group) and msP rats (n=25; 8–9/group)
were placed in the center (28×28 cm) of the open field arena,
and their activity was recorded for 15 min. Movement time,
total distance traveled, time spent in the center, and distance
traveled in the center were analyzed using the Activity
Monitor software (Med Associates).
Experiment 3: effect of ICV NPS treatment on elevated
plus maze task performance by msP and Wistar rats
The elevated plusmaze (EPM) taskwas performed in a sound-
attenuated room illuminated by a dim red light (~30 lx). The
apparatus consisted of four black wooden arms (50 cm
long×10 cm wide) arranged such that the respective closed
and open arms were opposite to each other. The maze, elevat-
ed 50 cm above the floor, was cleaned with water and dried
after each trial. Each 5-min trial began when the animals were
individually placed in the center of the maze, facing a closed
arm. A rat was considered to be on the central platform when
at least two of its paws were on it. An entry was defined as the
presence of all four paws in an arm. The percentage of time
spent in the open arms [% OAT= (time in open arms/time in
Bopen arms^+ time in Bclosed^ arms) ×100] and the percent-
age of open arm entries [%OAE= (number of open arm
entries/total number of Bopen^ or Bclosed^ arm entries)×100]
were considered as indexes of anxiety, and the total number of
arm entries was used as a measure of spontaneous locomotor
activity. The Wistar (n= 12/group) and msP rats (n = 14/
group) received an ICV injection of NPS (1.0 nmol/rat) or
its vehicle 5 min before the beginning of the task.
Experiment 4: effect of ICV NPS treatment
on discriminative cue-induced reinstatement of alcohol
seeking in Marchigian Sardinian alcohol-preferring rats
We previously demonstrated that ICV NPS treatment at doses
of 2.0 and 4.0, but not 1.0 nmol/rat, facilitated discriminative
cue-induced reinstatement of alcohol seeking in Wistar rats
(Cannella et al. 2009). Thus, we repeated this experiment in
msP rats (n=8).
The experiment consisted of three phases as follows: dis-
crimination, extinction, and reinstatement.
Discrimination phase Once saccharin was faded out, msP
rats were trained to discriminate between 10 % alcohol and
water in 30-min daily sessions. Discriminative and discrete
stimuli predictive of alcohol (S+) versus water availability
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(S−) were presented during the alcohol and water self-
administration sessions, respectively. The discriminative stim-
ulus for alcohol was the odor of orange extract, whereas water
availability (i.e., no reward) was signaled by anise extract. The
olfactory stimuli were generated by depositing six to eight
drops of the respective extract into the bedding in the operant
chamber. In addition, each lever press resulting in the delivery
of alcohol was followed by a 5-s time-out period (during
which the alcohol lever remained inactive) contingently paired
with the illumination of the chamber’s house light, which
served as a discrete stimulus. For the water sessions, the
time-out period was signaled by a 5-s 70-dB tone. The olfac-
tory discriminative stimuli for alcohol or water availability
were introduced 1 min before extension of the levers and
remained present throughout the 30-min sessions. The alcohol
and water sessions were conducted in a pseudorandom order
across distinct training days, with the constraint that all rats
received a total of 10 alcohol and 10 water sessions.
Extinction phase After the last conditioning day, rats were
subjected to a 30-min daily extinction session. Extinction
training was maintained until the responses on the previously
active lever dropped below 25 % of the baseline responses
under the S+ condition (average of the last three sessions) for
at least 2 days. During this phase, each trial began with the
extension of the levers without presentation of the conditioned
stimuli. Responses at the lever activated the delivery mecha-
nism but did not result in the delivery of liquids.
Reinstatement test Reinstatement tests began the day after
the last extinction session. The reinstatement test sessions
were identical to the discrimination phase sessions, except that
alcohol and water were not available. The rats were tested
under the S− condition on day 1 and under the S+ condition
from day 2 onward, with the S+ condition trials repeated every
third day. The effect of NPS (1.0, 2.0, or 4.0 nmol/rat) or its
vehicle on discriminative cue-induced reinstatement of alco-
hol seeking was evaluated using a Latin square within-
subjects counterbalanced design. NPS was injected to the
ICV 5 min before the test.
Experiment 5: effect of ICV NPS treatment
on extinguished alcohol seeking in msP and Wistar rats
TheWistar (n=8) andmsP (n=9) rats were trained for alcohol
self-administration as described for experiment 1. After the
last self-administration session, the rats were subjected to
30-min daily extinction sessions. During this phase, the re-
sponses at the active lever illuminated the house light and
activated the delivery mechanism but did not result in the
delivery of alcohol. Extinction training was maintained until
the response rate on the active lever dropped below 25 % of
the self-administration baseline rate (average of the last three
sessions) for at least 2 days. Once the extinction criteria were
achieved, the effect of NPS (0.1, 0.25, 0.5, 1.0, or 2.0 nmol/
rat) or its vehicle was evaluated under extinction conditions
using a Latin square within-subjects counterbalanced design.
Between the NPS treatments, trials under the extinction con-
dition were performed to confirm that the rats returned to meet
the extinction criteria. Thus, treatments were repeated every
third or fourth day depending on the time point of achieve-
ment of the extinction baseline.
Statistical analysis
Behavioral data were analyzed via between- and within-factor
ANOVAs as appropriate.
In experiment 1, the baseline lever press rate at 10 % alco-
hol self-administration was analyzed via two-way ANOVA,
with one factor between subjects (rat strain) and one factor
within subjects (reinforced/inactive lever responses). For this
analysis, we considered the lever responses averaged across
the last 3 days of self-administration. The effect of NPS on
alcohol self-administration was also analyzed via three-way
ANOVA, with rat strain as a between-subjects factor and NPS
dose and reinforced/inactive lever responses as within-
subjects factors. In experiment 2, the time spent and the dis-
tance traveled in the center of the arena and the total distance
traveled were analyzed via two-way ANOVA, with the rat
strain and NPS dose as between-subject factors. In experiment
3, the percentage of the time spent in open arms of the EPM
and the number of arm entries were analyzed via two-way
ANOVA. In experiment 4, the discrimination baseline was
analyzed via two-way ANOVA, with alcohol (S+)/water (S−)
conditions and reinforced/inactive lever responses as within-
subject factors. The extinction of lever pressing was analyzed
via two-way ANOVA, with active/inactive levers and extinc-
tion days as within-subject factors. The reinstatement test re-
sults were analyzed via two-way ANOVA, with extinction/S+/
S− conditions and active/inactive lever as within-subject fac-
tors; a response on the last extinction day and S+ responses
under drug vehicle treatment were used in this analysis. Drug
effects on discriminative cue-induced reinstatement of alcohol
seeking (S+ condition) were analyzed via a two-way within-
factors ANOVA (treatment and active/inactive lever). In ex-
periment 5, 10% alcohol self-administration training outcome
was analyzed as in experiment 1. The extinction of lever
pressing was analyzed via three-way ANOVA, with rat strain
as a between-subject factor and active/inactive levers and ex-
tinction days as within-subject factors. The effect of NPS on
extinguished alcohol seeking was analyzed via three-way
ANOVA, with rat strain as a between-subject factor and
active/inactive levers and NPS dose as the within-subject
factor. The analyses were followed by the Newman-Keuls
post hoc test when appropriate, and statistical significance
was set at p= 0.05.
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Results
Experiment 1: effect of ICV NPS treatment on alcohol
self-administration by msP and Wistar rats
One Wistar rat and one msP rat were excluded after the
angiotensin II test; thus, this experiment was performed
using seven rats per strain. For alcohol self-administra-
tion, the mean ± SEM alcohol consumption in the last
three training days was 1.28 and 0.83 g/kg body weight
of the msP and Wistar rats, respectively. When lever
pressing was evaluated via ANOVA, the statistical anal-
ysis revealed an overall effect of rat strain [F(1,
12) = 9.07; p< 0.05] and the reinforced/inactive response
× strain interaction [F(1, 12) = 10.69; p< 0.01]. These re-
sults agree with greater reinforcement of lever responses
by msP rats (Fig. 1). When the effect of NPS on alcohol
self-administration was analyzed, we found a dose ×
strain interaction [F(4, 48) = 4.16; p< 0.01] and a dose
× strain × lever interaction [F(4, 48) = 2.66; p < 0.05].
The Newman-Keuls post hoc test confirmed that NPS
treatment decreased the number of reinforcements re-
ceived by msP but not Wistar rats (Fig. 1). The number
of inactive lever responses was always low and was un-
affected by the experimental phase and pharmacological
treatment.
Experiment 2: effect of NPS on open field test
performance by msP and Wistar rats
All rats showed positive results on the angiotensin II test;
therefore, all rats were included in the statistical analysis.
For the time spent in the center of the arena, ANOVA
revealed an overall effect of strain [F(1, 43) = 8.94,
p< 0.01], and the overall effect of NPS dose approached
significance [F(2, 43) = 2.78, p= 0.073]. The strain × dose
interaction was also significant [F(2, 43) = 3.97, p< 0.05].
The Newman-Keuls post hoc test revealed that the msP rats
spent less time in the center of the arena than did the Wistar
rats (p< 0.01). NPS increased the time spent in the center
of the arena by the msP rats, but not the Wistar rats, in a
dose-dependent manner (p < 0.05, p < 0.01) (Fig. 2a).
When the distance traveled in the center was analyzed,
no significant effect of strain [F(1, 43) = 0,71, p NS] or
strain × dose interaction was observed [F(2, 43) = 0,26, p
NS], but there was a significant effect of dose [F(2, 43) = 5,
25, p< 0.01]. Although a dose-dependent trend of an in-
creased distance traveled in the center was observed in
both strains, the Newman-Keuls post hoc test did not find
any significant difference between the groups (Fig. 2b).
Finally, when the total distance traveled was analyzed,
there was a significant effect of strain [F(1, 43) = 10,35,
p< 0.01] but no significant effect of dose [F(2, 43) = 1,52,
p NS] or strain × dose interaction [F(2, 43) = 0,42, p NS].
The Newman-Keuls post hoc test did not indicate any dif-
ference between the two rat strains treated with the same
drug doses (Fig. 2c).
Experiment 3: effect of NPS on EPM task performance
by msP and Wistar rats
The overall ANOVA revealed a significant interstrain differ-
ence [F(1, 48) = 6.630; p<0.01] in the percentage of time
spent in the open arms. A significant treatment × strain inter-
action [F(1, 48)=9.184; p<0.001] was also observed. The
post hoc analysis revealed that the msP rats spent less time
in the open arms than did theWistar rats (p<0.01), suggesting
a higher level of anxiety among the msP rats (Fig. 3a). After
the injection of 1.0 nmol NPS/rat, the time spent in the open
arms by the msP rats increased (p<0.01), whereas no effect
was observed in the Wistar rats.
The overall ANOVA also revealed a significant treat-
ment × strain interaction [F(1, 48) = 7.677; p< 0.01] in
the number of open arm entries. The post hoc analysis
revealed that the msP rats entered the open arms fewer
times (p< 0.05) than did the Wistar rats. After the in-
jection of 1.0 nmol NPS/rat, the number of entries into
the open arms by the msP rats increased (p < 0.05),
Fig. 1 Effect of intracerebroventricular (ICV) administration of neuro-
peptide S (NPS) on 10 % alcohol self-administration by msP and Wistar
rats. The msP rats presented a higher baseline level of self-administration
before testing. Vehicle treatment did not affect alcohol self-administration
in either strain. ICV treatment with NPS reduced the number of 10 %
alcohol reinforcements received by the msP rats but not the Wistar rats
(upper panel), although the inactive lever response rate was not altered by
NPS treatment (lower panel). Reinforced and inactive lever presses are
reported in the upper and lower panels, respectively. The data are
expressed as the means ± SEM: ###p< 0.001 vs. Wistar rats under the
same conditions; ***p< 0.001 vs vehicle treatment in the same strain
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whereas no effect was observed in the Wistar rats
(Fig. 3b). Finally, no significant difference in the total
number of arm entries was detected (Fig. 3c).
Experiment 4: effect of ICV NPS treatment
on discriminative cue-induced reinstatement
of alcohol-seeking behavior in msP rats
All rats showed positive results on the angiotensin II test;
therefore, eight rats were included in the statistical analysis.
The mean ± SEM alcohol consumption of the last three
discrimination/training alcohol self-administration days
corresponded to 1.02 g/kg. When discrimination was evaluat-
ed by ANOVA, the statistical analysis revealed a significant
Fig. 2 Effect of ICVadministration of NPS on OFT performance by the
msP and Wistar rats. a Total time spent in the center of the open field
arena by the Wistar and msP rats. The msP rats spent less time in the
center of the arena than the Wistar rats. ICV treatment with NPS dose-
dependently increased the amount of time spent in the center of the arena
by the msP rats but not theWistar rats. bDistance traveled in the center of
the open field arena by the Wistar and msP rats. The msP and Wistar rats
traveled a similar distance in the center of the arena. ICV treatment with
NPS showed a non-significant trend of an increased distance traveled by
the msP rats and, to a lesser extent, the Wistar rats. c Total distance
traveled in the open field arena by the Wistar and msP rats. The Wistar
and msP rats traveled a similar total distance in the entire open field arena.
ICV treatment with NPS did not alter the total distance traveled by either
the Wistar or msP rats. The data are expressed as the means ± SEM:
##p< 0.01 vs Wistar rats at the same dose; *p< 0.05, **p< 0.01 vs vehi-
cle treatment in the same strain
Fig. 3 Effect of ICV NPS (1.0 nmol/rat) injection on elevated plus maze
(EPM) task performance. a The percentage of time spent in the open arms
was higher in the msP rats than in the Wistar rats. NPS administration
reversed anxiety-like behavior in the msP rats, whereas no effects were
detected in the Wistar rats. b The percentage of entries into the open arms
was significantly lower in the msP rats than in the Wistar rats.
Additionally, in this study, NPS specifically increased the percentage of
entries into the open arms in the msP rats. c The total number of arm
entries (open and closed arms) did not differ between the two strains and
was not affected by NPS injection. The data are expressed as the means
± SEM. Difference between the Wistar rats and the msP rats: ##p< 0.01
and #p< 0.05; the difference between NPS and vehicle; **p< 0.01 and
*p< 0.05
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effect of condition [F(1, 7)=93.42; p<0.0001], levers [F(1,
7) = 115.17; p<0.0001], and condition by lever interaction
[F(1, 7)=51.06; p<0.001], indicating that the rats successful-
ly discriminated between S+ and S− conditions (Fig. 4a). For
extinction training, the ANOVA revealed an overall effect of
levers [F(1, 7) = 40.44; p< 0.001], day [F(9, 63) = 10.06;
p<0.000001], and day by lever interaction [F(9, 63) =9.33;
p<0.000001]; the response on the active lever progressively
decreased until it was no longer different from the inactive
lever response (Fig. 4a). During the reinstatement test, expo-
sure to S+, but not S−, reinstated the response on the active
lever as demonstrated by an overall effect of levers [F(1,
7) = 116.25; p < 0.0001], conditions [F(2, 14) = 24.21;
p < 0.0001], and lever by condition interaction [F(2,
14)=9.40; p<0.01].
When the effect of NPS on cue-induced reinstatement was
analyzed, the ANOVA revealed that both overall effects of
treatment [F(3, 21) =0.58; p NS] and lever by treatment inter-
action [F(3, 21)=0.89; p NS] were not significant (Fig. 4b).
The inactive lever responses were always low and unaffected
by experimental phases and pharmacological treatments.
Experiment 5: effect of ICV NPS treatment
on extinguished alcohol seeking in msP and Wistar rats
One Wistar rat was excluded because it failed to reach the
extinction baseline, and one msP rat was excluded after the
angiotensin II test; thus, the analysis of this experiment was
performed in seven Wistar and eight msP rats. For alcohol
self-administration, the mean ±SEM alcohol consumption
in the last three training days was 1.07 and 0.67 g/kg in
msP and Wistar rats, respectively. When lever pressing
was evaluated via ANOVA, the statistical analysis re-
vealed a significant overall effect of strain [F(1,
13) = 5.41; p< 0.05] and lever × strain interaction [F(1,
13) = 8.11; p < 0.05], and these results were consistent
with a higher rate of reinforced lever responses by the
msP rats during baseline self-administration (Fig. 5a).
For extinction training, the ANOVA revealed a significant
lever × day × group interaction [F(11, 143) = 2.60;
p < 0.01]. As expected, at the beginning of extinction
training, the msP rats performed a greater number of ac-
tive lever presses than did the Wistar rats, confirming a
higher motivation for alcohol seeking among the msP rats.
At the end of the extinction phase, no differences in lever
pressing were observed between the msP and Wistar rats
(Fig. 5a). When the effect of NPS on extinguished alcohol
seeking was tested, the ANOVA revealed the overall ef-
fects of strain [F(1, 13) = 19.12; p < 0.001], dose [F(5,
65) = 10.34; p < 0.00001], and lever [F(1,13) = 64.19;
p< 0.00001] and a significant lever × dose × strain inter-
action [F(5,65) = 8.69; p< 0.00001]. The Newman-Keuls
post hoc test confirmed that the msP and Wistar rats ex-
hibited similar rates of lever responses under the vehicle
condition and that NPS reinstated the active lever re-
sponses in the Wistar but not in the msP rats (Fig. 5b).
Fig. 4 Effect of ICV administration of NPS on discriminative cue-
induced reinstatement of alcohol seeking in msP rats. a Baseline discrim-
ination between alcohol- (S+) andwater-paired (S−) environments, as well
as extinction training and S test results. The rats successfully discriminat-
ed between S+ and S− conditions, exhibiting higher alcohol reinforcement
than water reinforcement during discrimination training (Bas.). During
extinction, active lever pressing progressively decreased, and lever
pressing was sustained at the extinction level upon exposure to the S−
stimuli. b Effect of NPS on the S+ stimulus-induced reinstatement of
alcohol seeking. Exposure to alcohol-predictive discriminative stimuli
(S+) reinstated active lever pressing and this effect was not altered by
ICV administration of NPS. Reinforced and inactive lever presses are
presented in the upper and lower panels, respectively. The data are
expressed as the means ± SEM: ***p < 0.001, S+ vs S−
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Discussion
The results showed that NPS exerts distinct effects on alcohol
drinking and seeking depending on the genetic background. In
outbred Wistar rats, ICV injection of NPS did not modify
alcohol self-administration but elicited a marked increase in
lever pressing under the extinction condition suggestive of a
priming-like effect, leading to reinstatement of alcohol seek-
ing. This evidence expands our previous findings that central
NPS injection enhanced alcohol seeking and relapse elicited
by the presentation of discriminative cues signaling drug
availability (Cannella et al. 2009). When we administered
NPS to genetically selected msP rats, we recorded a complete-
ly different response to NPS: operant alcohol self-
administration was reduced and lever pressing under extinc-
tion conditions or following cue presentation were not in-
creased. These effects of NPS on lever pressing cannot be
attributed to changes in locomotor performance because the
total distance traveled in the OFTwas not modified by NPS at
the doses used here. Interestingly, however, when we mea-
sured the distance traveled and the time spent in the center
of the arena, we observed two important phenomena: (1) com-
pared to the Wistar rats, the msP rats spent less time and
showed lower locomotor activity in the center of the arena,
possibly reflecting higher anxiety and (2) the NPS administra-
tion ameliorated this difference by enhancing the center arena
performances of msP rats, indicating a rat strain-specific effect
of NPS.
In addition to having an innate high preference for alcohol
and for drinking excessive amounts of alcohol [6–8 g/kg body
weight per day (Ciccocioppo et al. 2006)], the msP rats are
highly sensitive to stress and stress-induced alcohol seeking
(Ciccocioppo 2013; Ciccocioppo et al. 2006), show
depressive-like traits (Ciccocioppo et al. 1999; Gozzi et al.
2013), and demonstrate an anxious-like phenotype that re-
covers following alcohol drinking (Ayanwuyi et al. 2013;
Cippitelli et al. 2015; Hansson et al. 2006). In fact, the msP
rats have been proposed to phenocopy animals in a
postdependent state (Ciccocioppo 2013; Ciccocioppo et al.
2006) that largely drink alcohol to self-medicate from nega-
tive effect and excessive anxiety.
NPS possesses marked anxiolytic effects in rodents; NPS
treatment increased the time spent in the open arms of the
EPM and the time spent in the light compartment of the light
dark box, reduced marble burring behavior in mice, and en-
hanced the locomotor activity in the central zone of the open
field (Jungling et al. 2008; Leonard et al. 2008; Meis et al.
2008; Xu et al. 2004). Therefore, we speculate that in the msP
rats, the inhibition of alcohol drinking by NPS reflects the
anxiolytic effect of this peptide, alleviating the anxiety of the
msP rats and attenuating their motivation for alcohol. This
hypothesis was confirmed by the results from the EPM task,
showing that the msP rats spent significantly less time in the
open arms of the apparatus than did theWistar rats. This result
confirmed a higher level of anxiety in the msP rats. Notably,
NPS injection increased the time spent in the open arms of the
EPM by the msP rats but not the Wistar rats. These rats
showed that NPS specifically exerts anxiolytic effects on
msP rats. A similar phenomenon was previously observed
for drugs such as nociception agonists and CRF1 receptor
antagonists; both classes of compounds possess marked anxi-
olytic effects and reduced alcohol drinking in msP rats but not
in heterogeneous Wistar rats (Ayanwuyi et al. 2013;
Ciccocioppo et al. 2014; de Guglielmo et al. 2015; Gehlert
Fig. 5 Effect of ICV administration of NPS on extinguished alcohol
seeking in the msP and Wistar rats. a Baseline self-administration and
extinction training. The msP rats exhibited a higher baseline level of
alcohol self-administration than the Wistar rats. During the first 2 days
of extinction training, the msP rats performed a greater number of active
lever presses than the Wistar rats, but both groups reached a similar level
of extinction after 12 days. b Effect of NPS on extinguished alcohol
seeking. ICV treatment with NPS reinstated the response to the active
lever in the Wistar rats but not the msP rats. No effects on presses of the
inactive control lever were detected. The data are expressed as the means
± SEM. Difference between msP and Wistar rats: #p < 0.05, ## p< 0.01;
difference between NPS and vehicle: ***p< 0.001
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et al. 2007). Most importantly, our finding agrees with previ-
ous studies published in genetically selected alcohol-
preferring P rats, in which ICVadministration of NPS attenu-
ated home cage alcohol drinking and elicited a marked anxi-
olytic effect (Badia-Elder et al. 2008). Similar to msP rats, P
rats are characterized by excessive alcohol drinking and ele-
vated anxiety (Stewart et al. 1993). Our results suggest that in
these alcohol-preferring rat strains, the inhibitory effect of
NPS on alcohol consumption is linked to the ability of NPS
to alleviate anxiety, despite the fact that NPS otherwise acts
via a negative reinforcement mechanism to provide an incen-
tive for alcohol consumption (Ciccocioppo et al. 2006;
Schank et al. 2012).
Previous studies using heterogeneous Wistar rats showed
that the permissive effect of NPS on cue-induced reinstate-
ment might depend on its ability to activate the orexin/
hypocretin system, as this effect was selectively blocked by
pretreatment with the hypocretin-1/orexin-A antagonist SB-
334867 (Cannella et al. 2009; Kallupi et al. 2010; Ubaldi et
al. 2016). Moreover, the orexin/hypocretin-facilitated condi-
tioned reinstatement of drug seeking is mediated by the direct
activation of two distinct Hcrt-1/Ox-A pathways linking the
lateral hypothalamus to the hypothalamic paraventricular nu-
cleus and the bed nucleus of the stria terminalis, which are
known to play a crucial role in the regulation of the stress
response (Ubaldi et al. 2016). In addition to these findings,
in cocaine-trained rats, ICV administration of NPS can rein-
state drug-seeking behavior under extinction conditions, mim-
icking a priming-like mechanism (Paneda et al. 2009). This
effect is prevented in animals carrying a genetic deletion of the
CRF1 receptor (Paneda et al. 2009). Hence, these data provide
further evidence of a tight link between the NPS system and
stress regulation. We speculate that when endogenous stress
systems are activated, NPS acts as a negative modulator of
these systems. When they are in a minimally active state,
stimulation of the orexin/hypocretin system promotes arousal
and facilitates goal-oriented responses. A tempting hypothesis
is that this highly evolutionarily conserved system
(Reinscheid 2007) is important for preserving natural instincts
in mammals by stimulating vigilance and arousal, which are
necessary to survival (i.e., hunting or escaping from a preda-
tor), and for preventing excessive stimulation of stress mech-
anisms leading to hyperanxiety, fear, and freezing responses
(Cannella et al. 2013).
In summary, our results suggest that due to its dualistic
nature, NPS acts differently between msP and Wistar rats. In
msP rats, the anxiolytic effects of NPS prevail, which results
in attenuating negative emotions (i.e., reduced anxiety) and
decreased incentives for alcohol. In heterogeneousWistar rats,
the pro-arousal and pro-stress properties of NPS predominate,
which translates into an enhanced alcohol-seeking response in
these animals. Future studies will need to determine the de-
tailed mechanisms underlying this dualistic action of NPS,
and the present study suggests that msP rats may represent
an important animal model for comparison with heteroge-
neous rats to explore this hypothesis.
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